S&P 500   4,604.37 (+0.41%)
DOW   36,247.87 (+0.36%)
QQQ   392.17 (+0.45%)
AAPL   195.71 (+0.74%)
MSFT   374.23 (+0.88%)
META   332.75 (+1.89%)
GOOGL   134.99 (-1.42%)
AMZN   147.42 (+0.37%)
TSLA   243.84 (+0.49%)
NVDA   475.06 (+1.95%)
NIO   7.39 (-1.34%)
BABA   72.16 (-0.24%)
AMD   128.92 (+0.43%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.96 (+1.78%)
CGC   0.80 (+11.11%)
GE   120.59 (+0.93%)
DIS   92.82 (+0.84%)
AMC   6.93 (+1.61%)
PFE   28.78 (+0.52%)
PYPL   58.94 (+0.79%)
XOM   99.55 (+1.15%)
S&P 500   4,604.37 (+0.41%)
DOW   36,247.87 (+0.36%)
QQQ   392.17 (+0.45%)
AAPL   195.71 (+0.74%)
MSFT   374.23 (+0.88%)
META   332.75 (+1.89%)
GOOGL   134.99 (-1.42%)
AMZN   147.42 (+0.37%)
TSLA   243.84 (+0.49%)
NVDA   475.06 (+1.95%)
NIO   7.39 (-1.34%)
BABA   72.16 (-0.24%)
AMD   128.92 (+0.43%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.96 (+1.78%)
CGC   0.80 (+11.11%)
GE   120.59 (+0.93%)
DIS   92.82 (+0.84%)
AMC   6.93 (+1.61%)
PFE   28.78 (+0.52%)
PYPL   58.94 (+0.79%)
XOM   99.55 (+1.15%)
S&P 500   4,604.37 (+0.41%)
DOW   36,247.87 (+0.36%)
QQQ   392.17 (+0.45%)
AAPL   195.71 (+0.74%)
MSFT   374.23 (+0.88%)
META   332.75 (+1.89%)
GOOGL   134.99 (-1.42%)
AMZN   147.42 (+0.37%)
TSLA   243.84 (+0.49%)
NVDA   475.06 (+1.95%)
NIO   7.39 (-1.34%)
BABA   72.16 (-0.24%)
AMD   128.92 (+0.43%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.96 (+1.78%)
CGC   0.80 (+11.11%)
GE   120.59 (+0.93%)
DIS   92.82 (+0.84%)
AMC   6.93 (+1.61%)
PFE   28.78 (+0.52%)
PYPL   58.94 (+0.79%)
XOM   99.55 (+1.15%)
S&P 500   4,604.37 (+0.41%)
DOW   36,247.87 (+0.36%)
QQQ   392.17 (+0.45%)
AAPL   195.71 (+0.74%)
MSFT   374.23 (+0.88%)
META   332.75 (+1.89%)
GOOGL   134.99 (-1.42%)
AMZN   147.42 (+0.37%)
TSLA   243.84 (+0.49%)
NVDA   475.06 (+1.95%)
NIO   7.39 (-1.34%)
BABA   72.16 (-0.24%)
AMD   128.92 (+0.43%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.96 (+1.78%)
CGC   0.80 (+11.11%)
GE   120.59 (+0.93%)
DIS   92.82 (+0.84%)
AMC   6.93 (+1.61%)
PFE   28.78 (+0.52%)
PYPL   58.94 (+0.79%)
XOM   99.55 (+1.15%)

PURE Bioscience (PURE) Earnings Date, Estimates & Call Transcripts

$0.13
+0.02 (+17.86%)
(As of 12/8/2023 ET)
Compare
Today's Range
$0.12
▼
$0.14
50-Day Range
$0.08
▼
$0.13
52-Week Range
$0.07
▼
$0.16
Volume
30,833 shs
Average Volume
34,523 shs
Market Capitalization
$14.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest

Earnings Summary

Upcoming
Earnings Date
Dec. 12Estimated
Actual EPS
(Oct. 30)
-$0.03 Missed By -$0.03
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

PURE Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PURE Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

PURE Earnings Date and Information

PURE Bioscience last issued its earnings data on October 30th, 2023. The reported ($0.03) EPS for the quarter. The company had revenue of $1.47 million for the quarter. PURE Bioscience has generated ($0.06) earnings per share over the last year (($0.06) diluted earnings per share). PURE Bioscience has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, December 12th, 2023 based off prior year's report dates.

PURE Bioscience Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
12/12/2023
Estimated)		------- 
10/30/2023Q4 2023-($0.03)($0.03)($0.03)-$1.47 million
6/14/2023Q3 2023-($0.01)($0.01)($0.01)-$0.41 million
3/17/2023Q2 2023-($0.01)($0.01)($0.01)-$0.40 million
12/14/2022Q1 2023-($0.01)($0.01)($0.01)-$0.47 million
10/28/2022Q4 2022-($0.01)($0.01)($0.01)-$0.40 million
6/14/2022Q3 2022-($0.01)($0.01)($0.01)-$0.50 million
3/15/2022Q2 2022-($0.01)($0.01)($0.01)-$0.42 million
12/15/2021Q1 2022-($0.01)($0.01)($0.01)-$0.50 million
10/28/2021Q4 2021-($0.01)($0.01)($0.01)-$0.86 million
6/15/2021Q3 2021-($0.01)($0.01)($0.01)-$0.56 million
3/15/2021Q2 2021-($0.01)($0.01)($0.01)-$0.92 million












PURE Bioscience Earnings - Frequently Asked Questions

When is PURE Bioscience's earnings date?

PURE Bioscience has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, December 12th, 2023 based off last year's report dates. Learn more on PURE's earnings history.

How much revenue does PURE Bioscience generate each year?

PURE Bioscience (OTCMKTS:PURE) has a recorded annual revenue of $1.87 million.

How much profit does PURE Bioscience generate each year?

PURE Bioscience (OTCMKTS:PURE) has a recorded net income of -$3.96 million. PURE has generated -$0.06 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (OTCMKTS:PURE) was last updated on 12/8/2023 by MarketBeat.com Staff

My Account -